No Data
No Data
No Data
No Data
No Data
Know Labs Initiated at Speculative Buy by Benchmark
Know Labs Initiated at Speculative Buy by Benchmark
Dow JonesApr 8 08:14 ET
Know Labs Price Target Announced at $1.00/Share by Benchmark
Know Labs Price Target Announced at $1.00/Share by Benchmark
Dow JonesApr 8 08:14 ET
Express News | Benchmark Initiates Coverage On Know Labs With Speculative Buy Rating, Announces Price Target of $1
Moomoo 24/7Apr 8 08:03 ET
Know Labs Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/08/2024 56.01% Benchmark → $1 Initiates Coverage On → Speculative Buy
BenzingaApr 8 08:02 ET
Know Labs to Present Clinical Research at the 2024 American Physiology Summit
The Company demonstrates significant progress since presenting at last year's Summit. Know Labs, Inc. (NYSE:KNW), an emerging developer of non-invasive medical diagnostic technology, today announced it has been
BusinesswireApr 5 09:00 ET
Know Labs Reports Promising Results From Clinical Study
TipRanksMar 6 16:25 ET
No Data
No Data